Dr. Sara K. Mclaughlin

Donna Martin is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Martin is highly rated in 1 condition, according to our data. Her clinical expertise encompasses CHARGE Syndrome and Neurofibromatosis Type 1 (NF1). Dr. Martin is board certified in American Board Of Medical Genetics And Genomics, Clinical Biochemical Genetics - 2023. Dr. Martin is currently accepting new patients.

Dr. Gregory Yanik has been a faculty member within the Blood and Marrow Transplant Program and Division at the University of Michigan since 1992. He was born and raised in the Detroit area, attended medical school at Wayne State University and trained in hematology-oncology at Cincinnati Children’s Hospital. He and his wife Marybeth have three grown children. Dr. Yanik has been the recipient of many prestigious awards in recognition of his contributions to medical research, clinical care, and education, including the Leland and Elaine Blatt Professorship of Pediatric Oncology, the University of Michigan Pediatric Teacher of the Year Award, and the Leukemia and Lymphoma Society Chairman’s Citation for Outstanding Service. Dr. Yanik is the founder of and chairs the Executive Committee for the Children’s Hematology Alliance of Michigan (CHAMI), a unique alliance of pediatric hematology/practice teams in the State of Michigan whose goal is to continuously improve the quality of care for children with these medical conditions regardless of where they are treated in the State. In addition to these many activities, Dr. Yanik makes time to serve on the Executive Committee for Make a Wish Michigan. Dr. Yanik is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Bronchiolitis Obliterans, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Graft Versus Host Disease (GvHD), and Lung Transplant. Dr. Yanik is currently accepting new patients.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Thyroid Cancer, Throat Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.